CDK4 and neoplasm: CDKN2A (also known as p16-INK4A) is a tumor suppressor that binds to the complex of cyclin D1 and cyclin-dependent kinase 4 to repress its ability to phosphorylate the retinoblastoma protein, and consequently, blocks cell cycle progression from G1 to S [67,68].